EA201690302A1 - Композиции для местного применения для лечения избыточного потоотделения и способы их применения - Google Patents

Композиции для местного применения для лечения избыточного потоотделения и способы их применения

Info

Publication number
EA201690302A1
EA201690302A1 EA201690302A EA201690302A EA201690302A1 EA 201690302 A1 EA201690302 A1 EA 201690302A1 EA 201690302 A EA201690302 A EA 201690302A EA 201690302 A EA201690302 A EA 201690302A EA 201690302 A1 EA201690302 A1 EA 201690302A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
treatment
compositions
methods
excess means
Prior art date
Application number
EA201690302A
Other languages
English (en)
Inventor
Теодора Кс. Пене-Думитреску
Элизабет К. Хасси
Мария Грациэлла Ларм
Джон Ленн
Леон Лупенок
Майкл Р. Люк
Леандро Л. Сантос
Вирджиния Д. Шмидт
Original Assignee
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51626097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201690302(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед filed Critical Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед
Publication of EA201690302A1 publication Critical patent/EA201690302A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится к 4-[гидрокси(дифенил)метил]-1-{2-[(фенилметил)окси]этил}-1-азониабицикло[2.2.2]октану и его фармацевтически приемлемому аниону для применения для местного лечения или профилактики избыточного потоотделения и к композициям, содержащим эти ингредиенты.
EA201690302A 2013-07-30 2014-07-30 Композиции для местного применения для лечения избыточного потоотделения и способы их применения EA201690302A1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361859947P 2013-07-30 2013-07-30
US201461952238P 2014-03-13 2014-03-13
US201462021878P 2014-07-08 2014-07-08
PCT/IB2014/063564 WO2015015446A1 (en) 2013-07-30 2014-07-30 Topical compositions for treatment of excessive sweating and methods of use thereof

Publications (1)

Publication Number Publication Date
EA201690302A1 true EA201690302A1 (ru) 2016-06-30

Family

ID=51626097

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690302A EA201690302A1 (ru) 2013-07-30 2014-07-30 Композиции для местного применения для лечения избыточного потоотделения и способы их применения

Country Status (17)

Country Link
US (2) US20150037269A1 (ru)
EP (1) EP3027184A1 (ru)
JP (1) JP2016525569A (ru)
KR (1) KR20160034920A (ru)
CN (1) CN105555269A (ru)
AU (1) AU2014297993A1 (ru)
BR (1) BR112016001696A2 (ru)
CA (1) CA2919979A1 (ru)
CR (1) CR20160055A (ru)
EA (1) EA201690302A1 (ru)
HK (1) HK1225317A1 (ru)
IL (1) IL243681A0 (ru)
MX (1) MX2016001465A (ru)
PE (1) PE20160198A1 (ru)
PH (1) PH12016500096A1 (ru)
SG (1) SG11201600045UA (ru)
WO (1) WO2015015446A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2952760A1 (en) 2014-06-18 2015-12-23 Cipla Limited Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent
HUE055663T2 (hu) 2015-07-21 2021-12-28 Bodor Laboratories Inc Készítmény lágy antikolinerg analógokhoz
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
WO2019072877A1 (en) * 2017-10-10 2019-04-18 Capsugel Belgium Nv GETTING MULTIPARTICULAR COMPOSITIONS
JP2022554264A (ja) * 2019-11-05 2022-12-28 ジャーニー メディカル コーポレーション 医薬組成物の手掌又は足底投与のための方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4885282A (en) 1987-07-02 1989-12-05 Thornfeldt Carl R Treatment of hyperhidrosis, ichthyosis and wrinkling
US5512555A (en) 1994-07-21 1996-04-30 Merck & Co., Inc. Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US8980290B2 (en) * 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
WO2004084905A2 (en) 2003-03-24 2004-10-07 University Of Florida Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
PT1729821E (pt) 2004-03-03 2013-10-23 Revance Therapeutics Inc Composições e métodos para aplicação tópica e administração transdérmica de toxinas botulínicas
PE20060259A1 (es) * 2004-04-27 2006-03-25 Glaxo Group Ltd Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico
US8618160B2 (en) * 2007-10-18 2013-12-31 Rose U Topical glycopyrrolate formulations
GB201113662D0 (en) * 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
CN104968656B (zh) * 2012-12-19 2017-08-11 诺华股份有限公司 自分泌运动因子抑制剂

Also Published As

Publication number Publication date
CN105555269A (zh) 2016-05-04
CR20160055A (es) 2016-04-04
CA2919979A1 (en) 2015-02-05
US20160166487A1 (en) 2016-06-16
PH12016500096A1 (en) 2016-04-18
US20150037269A1 (en) 2015-02-05
HK1225317A1 (zh) 2017-09-08
MX2016001465A (es) 2016-06-02
SG11201600045UA (en) 2016-02-26
IL243681A0 (en) 2016-04-21
BR112016001696A2 (pt) 2017-08-01
JP2016525569A (ja) 2016-08-25
AU2014297993A1 (en) 2016-02-04
WO2015015446A1 (en) 2015-02-05
KR20160034920A (ko) 2016-03-30
PE20160198A1 (es) 2016-04-21
EP3027184A1 (en) 2016-06-08

Similar Documents

Publication Publication Date Title
AU2018236800B2 (en) DNA-PK inhibitors
EA201792047A1 (ru) Новые соединения
MX2021001439A (es) Composiciones y metodos para el tratamiento de la disfuncion de la glandula de meibomio.
EA201891063A1 (ru) Производные дигидроимидазопиразинона, применимые в лечении рака
EA201691151A1 (ru) Соединения для лечения пациентов с ros1-мутантными раковыми клетками
EA201592068A1 (ru) Ингибиторы энхансера zeste гомолога 2
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201591591A1 (ru) Соединения карбазола, применяемые в качестве ингибиторов бромодомена
PH12015501609A1 (en) Phenicol antibacterials
EA201492216A1 (ru) Ингибиторы бромодомена и их применение
EA201690159A1 (ru) Способы и композиции для лечения рака
BR112015020139A2 (pt) compostos terapêuticos e usos dos mesmos
PH12016502353A1 (en) Pharmaceutical composition
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
EA201590183A1 (ru) Производные азаиндола, выступающие в качестве ингибиторов pi3k
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
EA201600434A1 (ru) Применение производных бензимидазолпролина
EA201690302A1 (ru) Композиции для местного применения для лечения избыточного потоотделения и способы их применения
EA201590364A1 (ru) Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда
MY176521A (en) Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising the same and use thereof
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
BR112018073419A2 (pt) combinação, uso da combinação, método para o tratamento, composto, método para o tratamento de doença de alzheimer e composição farmacêutica
IN2015DN02109A (ru)
MX2016004094A (es) Composicion farmaceutica que comprende capecitabina y ciclofosfamida.
EA201792170A1 (ru) Производные индола